A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder
NCT ID: NCT07033416
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2026-03-31
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question this clinical trial aims to answer is how many days participants can be in abstinence from cocaine after 4 ABM sessions.
ABM is a computerised training aiming to train the participants to:
* avoid drug-related images by pushing a joystick which causes the image to disappear;
* approach positive images by pulling a joystick which causes the image to expand.
Researchers will compare participants treated with ABM to those who receive Treatment As Usual (TAU) condition to see if ABM training for CUD is more effective in increasing the number of abstinent days.
* Participants will attend 1 ABM session per week for a total of 4 sessions, each lasting 15 minutes.
* Both cocaine and non-cocaine positive images relative to the subjective values or interests (i.e. effects, sport, music, nature, work, etc.) are presented to the participant, in portrait or landscape orientation.
* Participants are instructed to push the joystick if the image is portrait-oriented (cocaine-related images) or to pull the joystick if it is landscape-oriented (positive images).
* At 1 and 3-month-follow up, participants will complete self-report questionnaires to measure abstinence days and describe the effect of ABM on cocaine use, dependence symptoms, and approach bias.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ABM+TAU
Participants treated with the experimental training Approach Bias Modification (ABM), and the usual treatment (Treatment As Usual, TAU).
Approach Bias Modification
ABM is a computerised training aiming to train the participants to avoid drug-related images (by pushing a joystick which causes the image to disappear) and approach positive images (by pulling a joystick which causes the image to expand). Each training session lasts 15 minutes and it takes place once per week for 4 weeks.
Treatment as usual
Participants receiving TAU are not trained to avoid drug-related images and approach positive images.
TAU
Participants treated with the usual treatment (Treatment As Usual, TAU).
Treatment as usual
Participants receiving TAU are not trained to avoid drug-related images and approach positive images.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Approach Bias Modification
ABM is a computerised training aiming to train the participants to avoid drug-related images (by pushing a joystick which causes the image to disappear) and approach positive images (by pulling a joystick which causes the image to expand). Each training session lasts 15 minutes and it takes place once per week for 4 weeks.
Treatment as usual
Participants receiving TAU are not trained to avoid drug-related images and approach positive images.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current DSM 5 TR Cocaine Use Disorder;
* sufficient Italian language proficiency to understand the participant information sheet, questionnaires and intervention task instructions;
* signed Consent form.
Exclusion Criteria
* neurological disorder or injury or brain trauma involving loss of consciousness for longer than 30 minutes;
* severe psychiatric disorder, as evaluated by clinical judgement;
* antipsychotic medication;
* intellectual disability;
* missing Informed Consent;
* planned absence from attendance through the training period (one month).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Monash University
OTHER
ASST Fatebenefratelli Sacco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doriana Losasso, Psych
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Doriana Losasso
Role: PRINCIPAL_INVESTIGATOR
ASST Fatebenefratelli Sacco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Struttura Semplice Servizio Dipendenze
Milan, Milano, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Doriana Losasso
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABMCocaine
Identifier Type: -
Identifier Source: org_study_id